Wei Xu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Wei Xu has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Jiahui Xu
School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China
4 shared publications - Jixin Li
School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China
4 shared publications - Jiatong Liu
College of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China
3 shared publications - Jingying Li
School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China
3 shared publications - Lin Wang
School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China
3 shared publications - Xuehui Ding
School of Pharmacy, Changchun University of Chinese Medicine, Changchun 130117, China
3 shared publications
Latest Publications
- Open Access
- 16 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9201
Fenvalerate Induces Airway Epithelial Injury Through CHRM3-Associated NF-κB Activation
Fenvalerate (FEN) is a widely used pyrethroid insecticide with potential respiratory toxicity; however, its contribution to chronic obstructive pulmonary disease (COPD)-related pathological processes remains unclear. We investigated molecular mechanisms linking FEN exposure to airway epithelial injury. COPD transcriptomic datasets were integrated with predicted FEN targets, and candidate genes were prioritized using machine-learning algorithms. Immune infiltration and single-cell transcriptomic analyses were used to examine immune associations and cell-type-specific expression. Molecular docking and molecular dynamics simulations assessed potential FEN-target interactions, followed by validation in BEAS-2B human bronchial epithelial cells. Intersecting FEN-COPD genes were enriched in inflammatory, immune-regulatory, neuroactive ligand-receptor, and epithelial injury-related pathways. Eight candidate genes showed distinct expression patterns across airway epithelial and immune cell populations. Computational analyses supported a potentially stable FEN-CHRM3 interaction. In BEAS-2B cells, FEN reduced viability, increased IL-6 and IL-8 secretion, promoted apoptosis, upregulated CHRM3, and enhanced IκBα and p65 phosphorylation. Pharmacological inhibition of CHRM3 or NF-κB partially attenuated these responses. Thus, FEN-induced epithelial inflammation and apoptosis may involve CHRM3-associated NF-κB activation, providing mechanistic insight into pesticide-related respiratory toxicity.
- 16 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9201
Open AccessFenvalerate Induces Airway Epithelial Injury Through CHRM3-Associated NF-κB Activation
Fenvalerate (FEN) is a widely used pyrethroid insecticide with potential respiratory toxicity; however, its contribution to chronic obstructive pulmonary disease (COPD)-related pathological processes remains unclear. We investigated molecular mechanisms linking FEN exposure to airway epithelial injury. COPD transcriptomic datasets were integrated with predicted FEN targets, and candidate genes were prioritized using machine-learning algorithms. Immune infiltration and single-cell transcriptomic analyses were used to examine immune associations and cell-type-specific expression. Molecular docking and molecular dynamics simulations assessed potential FEN-target interactions, followed by validation in BEAS-2B human bronchial epithelial cells. Intersecting FEN-COPD genes were enriched in inflammatory, immune-regulatory, neuroactive ligand-receptor, and epithelial injury-related pathways. Eight candidate genes showed distinct expression patterns across airway epithelial and immune cell populations. Computational analyses supported a potentially stable FEN-CHRM3 interaction. In BEAS-2B cells, FEN reduced viability, increased IL-6 and IL-8 secretion, promoted apoptosis, upregulated CHRM3, and enhanced IκBα and p65 phosphorylation. Pharmacological inhibition of CHRM3 or NF-κB partially attenuated these responses. Thus, FEN-induced epithelial inflammation and apoptosis may involve CHRM3-associated NF-κB activation, providing mechanistic insight into pesticide-related respiratory toxicity.
- Open Access
- 15 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9143
Potential Molecular Links Between Triclosan Exposure and Prostate Cancer: An Integrative Computational Analysis
Triclosan (TCS) is a widely used antimicrobial and endocrine-disrupting chemical whose potential relevance to prostate cancer (PCa) biology remains insufficiently understood. We integrated multi-omics and computational analyses to identify candidate targets that overlap between predicted TCS-related molecular targets and PCa-related transcriptomic alterations. Cross-database target mapping, differential expression, and network analyses were combined with machine learning, molecular docking, molecular dynamics simulations, Mendelian randomization, and single-cell transcriptomic profiling. Pathway analyses highlighted oxidative stress and metabolic dysregulation as key processes shared between predicted TCS-related targets and PCa-associated transcriptomic alterations. Machine learning prioritized five candidate genes—FERMT2, F5, PRKCA, ABCC4, and ACOX2—with discriminative value for PCa classification in the analyzed cohorts. Docking and molecular dynamics simulations supported plausible binding compatibility of TCS to ABCC4 and ACOX2. Mendelian randomization suggested that genetically predicted ABCC4 expression may be associated with PCa risk. Single-cell analysis further showed cell-type-specific expression of candidate genes in tumor-enriched epithelial populations. These findings provide an integrative framework for generating mechanistic hypotheses on how TCS-related molecular targets may be associated with PCa biology.
- 15 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9143
Open AccessPotential Molecular Links Between Triclosan Exposure and Prostate Cancer: An Integrative Computational Analysis
Triclosan (TCS) is a widely used antimicrobial and endocrine-disrupting chemical whose potential relevance to prostate cancer (PCa) biology remains insufficiently understood. We integrated multi-omics and computational analyses to identify candidate targets that overlap between predicted TCS-related molecular targets and PCa-related transcriptomic alterations. Cross-database target mapping, differential expression, and network analyses were combined with machine learning, molecular docking, molecular dynamics simulations, Mendelian randomization, and single-cell transcriptomic profiling. Pathway analyses highlighted oxidative stress and metabolic dysregulation as key processes shared between predicted TCS-related targets and PCa-associated transcriptomic alterations. Machine learning prioritized five candidate genes—FERMT2, F5, PRKCA, ABCC4, and ACOX2—with discriminative value for PCa classification in the analyzed cohorts. Docking and molecular dynamics simulations supported plausible binding compatibility of TCS to ABCC4 and ACOX2. Mendelian randomization suggested that genetically predicted ABCC4 expression may be associated with PCa risk. Single-cell analysis further showed cell-type-specific expression of candidate genes in tumor-enriched epithelial populations. These findings provide an integrative framework for generating mechanistic hypotheses on how TCS-related molecular targets may be associated with PCa biology.
- Open Access
- 13 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9056
Prediction of Lindane-Induced Breast Cancer Toxicity Through Multi-Target Network Analysis and Mechanistic Investigation
This study aimed to identify potential molecular targets associated with Lindane-induced molecular alterations in breast cancer and elucidate its toxicological mechanisms using an integrated strategy combining network toxicology, machine learning, molecular simulation, and experimental validation. Lindane-related targets and breast cancer transcriptomic data were collected from public databases, and differentially expressed genes and WGCNA-derived hub genes were integrated to identify candidate targets. GO and KEGG analyses were performed to explore biological functions, while machine learning models and SHAP analysis were applied to screen potential biomarkers. Molecular docking and 100 ns molecular dynamics simulations were conducted to evaluate the interaction between Lindane and key proteins. Twenty-eight overlapping targets were identified and mainly enriched in lipid metabolism, sphingolipid signaling, and p53-related pathways. The LASSO-plsRglm model achieved the highest average AUC (0.996) and identified five candidate genes, including NR3C2, AR, TGM2, ATAD2, and P2RY2. NR3C2 exhibited strong discriminatory performance (AUC = 0.982) and was consistently downregulated in breast cancer tissues. Molecular simulations suggested a potential interaction between Lindane and NR3C2. Cell experiments using human breast cancer MCF-7 cells demonstrated that Lindane increased intracellular ROS accumulation and promoted apoptosis, accompanied by decreased NR3C2 expression, upregulation of TGM2 and ATAD2, increased p53, Bax, and cleaved caspase-3 protein levels, and reduced Bcl-2 expression. NR3C2 may serve as a potential regulatory molecule involved in cellular responses to Lindane exposure in breast cancer, providing new insights into the molecular mechanisms underlying environmental Lindane exposure and breast cancer-related toxicity.
- 13 October 2026
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (20) , 9056
Open AccessPrediction of Lindane-Induced Breast Cancer Toxicity Through Multi-Target Network Analysis and Mechanistic Investigation
This study aimed to identify potential molecular targets associated with Lindane-induced molecular alterations in breast cancer and elucidate its toxicological mechanisms using an integrated strategy combining network toxicology, machine learning, molecular simulation, and experimental validation. Lindane-related targets and breast cancer transcriptomic data were collected from public databases, and differentially expressed genes and WGCNA-derived hub genes were integrated to identify candidate targets. GO and KEGG analyses were performed to explore biological functions, while machine learning models and SHAP analysis were applied to screen potential biomarkers. Molecular docking and 100 ns molecular dynamics simulations were conducted to evaluate the interaction between Lindane and key proteins. Twenty-eight overlapping targets were identified and mainly enriched in lipid metabolism, sphingolipid signaling, and p53-related pathways. The LASSO-plsRglm model achieved the highest average AUC (0.996) and identified five candidate genes, including NR3C2, AR, TGM2, ATAD2, and P2RY2. NR3C2 exhibited strong discriminatory performance (AUC = 0.982) and was consistently downregulated in breast cancer tissues. Molecular simulations suggested a potential interaction between Lindane and NR3C2. Cell experiments using human breast cancer MCF-7 cells demonstrated that Lindane increased intracellular ROS accumulation and promoted apoptosis, accompanied by decreased NR3C2 expression, upregulation of TGM2 and ATAD2, increased p53, Bax, and cleaved caspase-3 protein levels, and reduced Bcl-2 expression. NR3C2 may serve as a potential regulatory molecule involved in cellular responses to Lindane exposure in breast cancer, providing new insights into the molecular mechanisms underlying environmental Lindane exposure and breast cancer-related toxicity.
- Open Access
- 26 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11449
Formulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis
Sinomenine (SIN), as a potential therapeutic agent for rheumatoid arthritis (RA), exhibits advantages such as non-addictiveness. However, its low aqueous solubility and poor membrane permeability result in limited bioavailability, which compromises its therapeutic efficacy in conventional formulations. To address these limitations, this study developed nanostructured lipid carriers (NLCs) with optimized formulations and evaluated their pharmacodynamic performance. Molecular dynamics (MD) simulations were employed to screen excipients and analyze the blending system. SIN-loaded NLCs (SIN-NLCs) were prepared using high-pressure homogenization. Single-factor experiments were performed to optimize the processing conditions of SIN-NLCs. A three-factor, three-level experimental design was established using Design Expert 13 software and further refined through Box–Behnken design (BBD) response surface methodology. This approach enabled cross-validation between molecular dynamics simulations and conventional experiments. Additionally, transmission electron microscopy (TEM) was used to examine morphology, while X-ray diffraction analysis (XRD), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FT-IR) were employed to characterize the physicochemical state of SIN in NLCs. Pharmacodynamic evaluation was performed in a RA model, supplemented by single-pass intestinal perfusion study (SPIP). Initially, MD simulations were employed to evaluate drug–excipient compatibility, thereby identifying suitable formulation excipients: stearic acid and oleic acid as lipid components, and Poloxamer 188 as the surfactant. Subsequently, single-factor experiments combined with the BBD response surface methodology were employed to optimize preparation parameters, establishing the ideal process conditions: drug-to-lipid ratio of 1:42, solid-to-liquid lipid ratio of 5.58:4.42, and Poloxamer 188 concentration of 1.20%. The optimized SIN-NLCs exhibited spherical particles with uniform dispersion and no agglomeration. The average particle size was 173.90 ± 1.97 nm, with a polydispersity index (PDI) of 0.18 ± 0.01, a zeta potential of −22.65 ± 0.60 mV, and an encapsulation efficiency (EE%) of 91.27% ± 0.01. Spectroscopic analysis confirmed that SIN existed in an amorphous state and was successfully encapsulated within the lipid matrix. In vivo, SIN-NLCs significantly reduced paw swelling and arthritis scores in model rats, promoted synovial cell proliferation, and suppressed inflammatory cell infiltration. The intestinal perfusion study demonstrated that SIN-NLCs were primarily absorbed in the small intestine and markedly enhanced drug permeability. SIN-NLCs represent an effective delivery system to enhance the solubility and permeability of SIN. This study provides a novel strategy and methodology for the formulation of hydrophobic drugs, offering valuable insights for future pharmaceutical development.
- 26 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (23) , 11449
Open AccessFormulation Optimization of Sinomenine-Loaded Nanostructured Lipid Carriers Based on Molecular Dynamics Simulations and Evaluation of Pharmacological Efficacy in Rheumatoid Arthritis
Sinomenine (SIN), as a potential therapeutic agent for rheumatoid arthritis (RA), exhibits advantages such as non-addictiveness. However, its low aqueous solubility and poor membrane permeability result in limited bioavailability, which compromises its therapeutic efficacy in conventional formulations. To address these limitations, this study developed nanostructured lipid carriers (NLCs) with optimized formulations and evaluated their pharmacodynamic performance. Molecular dynamics (MD) simulations were employed to screen excipients and analyze the blending system. SIN-loaded NLCs (SIN-NLCs) were prepared using high-pressure homogenization. Single-factor experiments were performed to optimize the processing conditions of SIN-NLCs. A three-factor, three-level experimental design was established using Design Expert 13 software and further refined through Box–Behnken design (BBD) response surface methodology. This approach enabled cross-validation between molecular dynamics simulations and conventional experiments. Additionally, transmission electron microscopy (TEM) was used to examine morphology, while X-ray diffraction analysis (XRD), differential scanning calorimetry (DSC), and Fourier-transform infrared spectroscopy (FT-IR) were employed to characterize the physicochemical state of SIN in NLCs. Pharmacodynamic evaluation was performed in a RA model, supplemented by single-pass intestinal perfusion study (SPIP). Initially, MD simulations were employed to evaluate drug–excipient compatibility, thereby identifying suitable formulation excipients: stearic acid and oleic acid as lipid components, and Poloxamer 188 as the surfactant. Subsequently, single-factor experiments combined with the BBD response surface methodology were employed to optimize preparation parameters, establishing the ideal process conditions: drug-to-lipid ratio of 1:42, solid-to-liquid lipid ratio of 5.58:4.42, and Poloxamer 188 concentration of 1.20%. The optimized SIN-NLCs exhibited spherical particles with uniform dispersion and no agglomeration. The average particle size was 173.90 ± 1.97 nm, with a polydispersity index (PDI) of 0.18 ± 0.01, a zeta potential of −22.65 ± 0.60 mV, and an encapsulation efficiency (EE%) of 91.27% ± 0.01. Spectroscopic analysis confirmed that SIN existed in an amorphous state and was successfully encapsulated within the lipid matrix. In vivo, SIN-NLCs significantly reduced paw swelling and arthritis scores in model rats, promoted synovial cell proliferation, and suppressed inflammatory cell infiltration. The intestinal perfusion study demonstrated that SIN-NLCs were primarily absorbed in the small intestine and markedly enhanced drug permeability. SIN-NLCs represent an effective delivery system to enhance the solubility and permeability of SIN. This study provides a novel strategy and methodology for the formulation of hydrophobic drugs, offering valuable insights for future pharmaceutical development.
- Open Access
- 5 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10773
Preparation of Lipid Cubic Liquid Crystalline Nanoparticles of Sinomenine Based on Molecular Dynamics Simulations and Investigation of the Efficacy Against Rheumatoid Arthritis
Sinomenine (SIN) is a promising candidate for the treatment of rheumatoid arthritis (RA). Although it possesses the advantage of being non-addictive, its poor aqueous solubility and low oral bioavailability have limited its clinical application. To address these issues, SIN was encapsulated into lipid cubic liquid crystal nanoparticles (LCNPs) and systematically characterized. Molecular dynamics (MD) simulations were first employed to screen suitable excipients for formulation development. Combined with single-factor optimization and Box–Behnken response surface design, the optimal composition and preparation process were determined. The resulting SIN-LCNPs exhibited a particle size of 149.7 ± 0.9 nm, a polydispersity index (PDI) of 0.223 ± 0.01, a zeta potential of −18.9 mV, and an encapsulation efficiency (EE%) of 92.2%. Spectroscopic analyses confirmed successful incorporation of SIN into the lipid matrix. Pharmacodynamic studies revealed that SIN-LCNPs enhanced targeted drug delivery to inflamed joints, significantly alleviating inflammation and suppressing disease progression in rats. In vivo single-pass intestinal perfusion (SPIP) experiments further demonstrated that SIN was primarily absorbed through the small intestine and that the LCNP carrier effectively improved its intestinal permeability. Collectively, this study provides a novel strategy and theoretical foundation for developing efficient formulations of poorly water-soluble drugs, highlighting the potential clinical application of SIN-LCNPs in RA therapy.
- 5 November 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (21) , 10773
Open AccessPreparation of Lipid Cubic Liquid Crystalline Nanoparticles of Sinomenine Based on Molecular Dynamics Simulations and Investigation of the Efficacy Against Rheumatoid Arthritis
Sinomenine (SIN) is a promising candidate for the treatment of rheumatoid arthritis (RA). Although it possesses the advantage of being non-addictive, its poor aqueous solubility and low oral bioavailability have limited its clinical application. To address these issues, SIN was encapsulated into lipid cubic liquid crystal nanoparticles (LCNPs) and systematically characterized. Molecular dynamics (MD) simulations were first employed to screen suitable excipients for formulation development. Combined with single-factor optimization and Box–Behnken response surface design, the optimal composition and preparation process were determined. The resulting SIN-LCNPs exhibited a particle size of 149.7 ± 0.9 nm, a polydispersity index (PDI) of 0.223 ± 0.01, a zeta potential of −18.9 mV, and an encapsulation efficiency (EE%) of 92.2%. Spectroscopic analyses confirmed successful incorporation of SIN into the lipid matrix. Pharmacodynamic studies revealed that SIN-LCNPs enhanced targeted drug delivery to inflamed joints, significantly alleviating inflammation and suppressing disease progression in rats. In vivo single-pass intestinal perfusion (SPIP) experiments further demonstrated that SIN was primarily absorbed through the small intestine and that the LCNP carrier effectively improved its intestinal permeability. Collectively, this study provides a novel strategy and theoretical foundation for developing efficient formulations of poorly water-soluble drugs, highlighting the potential clinical application of SIN-LCNPs in RA therapy.
- Open Access
- 29 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (23) , 12863
Prescription Design of Sinomenine Gel Based on Molecular Dynamics Simulations
Sinomenine (SIN) is a drug for the treatment of rheumatoid arthritis, most of which is administered orally, but it is prone to adverse gastrointestinal effects. Gel can overcome the gastrointestinal adverse effects caused by oral administration. In this paper, a multiscale computational pharmaceutics strategy was developed to guide the systematic study of formulation factors of a SIN gel and, further, to guide the formulation design. A molecular dynamics (MD) simulations method was utilized to successfully screen the optimal prescription of SIN gel and to elucidate the molecular mechanisms affecting the quality of SIN gel. The optimal prescription was 3.0% of SIN, 1.0% of Carbopol (Cp), 30% of Ethanol (Eth), 5.0% of Glycerine (Gly) and 10.0% of Menthol (Men). The influence mechanism can be explained by the combination of multiple parameters, such as the microstructure diagram, the radius of gyration (Rg) and the radial distribution function (RDF). In vitro transdermal studies were carried out using a modified Franz diffusion cell method to evaluate the quality of the screened and reference prescriptions. The results showed that the cumulative penetration and penetration rate of the screening of prescription were better than the reference formulation. Most important of all, the simulation results are in good agreement with the in vitro release experiment, indicating that the strategy has good applicability. This study was able to accurately optimize the formulation and elucidate the molecular mechanism, which would provide a reference for further research on SIN and gel.
- 29 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (23) , 12863
Open AccessPrescription Design of Sinomenine Gel Based on Molecular Dynamics Simulations
Sinomenine (SIN) is a drug for the treatment of rheumatoid arthritis, most of which is administered orally, but it is prone to adverse gastrointestinal effects. Gel can overcome the gastrointestinal adverse effects caused by oral administration. In this paper, a multiscale computational pharmaceutics strategy was developed to guide the systematic study of formulation factors of a SIN gel and, further, to guide the formulation design. A molecular dynamics (MD) simulations method was utilized to successfully screen the optimal prescription of SIN gel and to elucidate the molecular mechanisms affecting the quality of SIN gel. The optimal prescription was 3.0% of SIN, 1.0% of Carbopol (Cp), 30% of Ethanol (Eth), 5.0% of Glycerine (Gly) and 10.0% of Menthol (Men). The influence mechanism can be explained by the combination of multiple parameters, such as the microstructure diagram, the radius of gyration (Rg) and the radial distribution function (RDF). In vitro transdermal studies were carried out using a modified Franz diffusion cell method to evaluate the quality of the screened and reference prescriptions. The results showed that the cumulative penetration and penetration rate of the screening of prescription were better than the reference formulation. Most important of all, the simulation results are in good agreement with the in vitro release experiment, indicating that the strategy has good applicability. This study was able to accurately optimize the formulation and elucidate the molecular mechanism, which would provide a reference for further research on SIN and gel.